Atrial Sensing Capability for Better Detection of Atrial Fibrillatio
- Conditions
- Injury, poisoning and certain other consequences of external causes
- Registration Number
- KCT0003893
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 280
Eligible patients for the present study are those who will undergo or have undergone implantation of Intrica 7 VR-T DX ICD with atrial sensing function(Biotronik, Germany) within previous 90 days before enrollment. Inclusion criteria are as follows: 1) age = 19 years, 2) indication for ICDimplantationaccording to guidelines 3) atrial fibrillation didn't detect by ECG or holter test within the past 1 year from the ICD implantation, and 4) CHA2DS2VASc score =1 point in male or = 2 in female
Patients who met any of the following criteria are excluded: 1) persistent or permanent atrial fibrillation (AF) 2) atrial fibrillation detected by electrocardiogram or holter test within the past 1 year from the ICD implantation 3)history of catheter or surgical ablation of AF or taking anti arrhythmic drug, 4) scheduled to undergo heart transplant within 1 year, 5)life expectancy < 1 year, or 6) requiring atrial pacing.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cardiac implantable electronic device-detected or clinical atrial fibrillation
- Secondary Outcome Measures
Name Time Method Complications associated with atrial fibrillation;ventricular arrhythmia;major adverse composie events;atrial lead sensing stability